Aviv Regev, Executive Vice President and Head of Genentech Research and Early Development, shares how Genentech is leveraging AI on AWS to accelerate drug discovery. With its lab-in-the-loop, Genentech has embedded AI into 100% of its antibody programs and the majority of its small molecule programs—enabling breakthroughs like early immunogenicity risk detection and resolution that keep their fastest-moving programs on track and more likely to succeed. And with its research agent, Genentech is putting AI in the hands of its scientists to improve their chain of thought, and enable them to ask questions they were not able to before.
Subscribe to AWS: https://go.aws/subscribe
Create a free AWS account: https://go.aws/signup
Try AWS for free: https://go.aws/free
Connect with an expert: https://go.aws/contact
Explore more: https://go.aws/more
Next steps:
Explore on AWS in Analyst Research: https://go.aws/reports
Discover, deploy, and manage software that runs on AWS: https://go.aws/marketplace
Join the AWS Partner Network: https://go.aws/partners
Learn more on how Amazon builds and operates software: https://go.aws/library
Do you have technical AWS questions?
Ask the community of experts on AWS re:Post: https://go.aws/3lPaoPb
Why AWS?
Amazon Web Services is the world’s most comprehensive and broadly adopted cloud, enabling customers to build anything they can imagine. We offer the greatest choice of innovative cloud capabilities and expertise, on the most extensive global infrastructure with industry-leading security, reliability, and performance.
#AWS #AmazonWebServices #CloudComputing
